Empowered Patient Podcast

Daniel O'Connor, CEO, OncoSec Immunotherapies describes their intratumoral therapy where the drug is injected directly into tumors instead of a systemic treatment thereby avoiding toxicities while also seeing tumors shrink that are not being directly treated, the abscopal effect. OncoSec is using electroporation to deliver interleukin-12 into cells. IL-12 is considered to be one of the most potent cytokines to fight cancer and their drug TAVO is being tested in conjunction with KEYTRUDA to help patients with melanoma not responding to current treatments.

@oncosec #oncology #cancer #interleukin-12 #IL-12 #melanoma #breastcancer #TAVO #immunotherapy $ONCS

OncoSec.com

Listen to the podcast here

Daniel O'Connor, CEO, OncoSec Immunotherapies describes their intratumoral therapy where the drug is injected directly into tumors instead of a systemic treatment thereby avoiding toxicities while also seeing tumors shrink that are not being directly treated, the abscopal effect. OncoSec is using electroporation to deliver interleukin-12 into cells. IL-12 is considered to be one of the most potent cytokines to fight cancer and their drug TAVO is being tested in conjunction with KEYTRUDA to help patients with melanoma not responding to current treatments.

@oncosec #oncology #cancer #interleukin-12 #IL-12 #melanoma #breastcancer #TAVO #immunotherapy $ONCS

OncoSec.com

Download the transcript here

Dr. Bill Audeh, medical oncologist and Chief Medical Officer, Agendia left his 30 year career of medical practice treating breast cancer patients to join Agendia because of the exciting opportunities for precision medicine to treat breast cancer. With technology that allows for genomic testing of the cancer tumors, it can be determined how likely it is that the cancer could spread and identifies what's driving the cancer's growth. With this data, physicians can be informed about the best treatment for each individual patient.

@agendia #precisionmedicine #genomictesting #breastcancer

Agendia.com

Listen to the podcast here

Dr. Bill Audeh, medical oncologist and Chief Medical Officer, Agendia left his 30 year career of medical practice treating breast cancer patients to join Agendia because of the exciting opportunities for precision medicine to treat breast cancer. With technology that allows for genomic testing of the cancer tumors, it can be determined how likely it is that the cancer could spread and identifies what's driving the cancer's growth. With this data, physicians can be informed about the best treatment for each individual patient.

@agendia #precisionmedicine #genomictesting #breastcancer

Agendia.com

Download the transcript here

Catherine Rivier, Co-Founder Sentia Medical is an expert on stressors and the impact physical, emotional, and infectious or inflammatory stressors have on the brain and the body. Her research along with her late husband at the Salk Institute in San Diego led to the discovery of the main stress hormone CRF. Sentia is now developing astressins - compounds that will counter some of the effects of stressor on the body. Their focus is treating irritable bowel syndrome, a key stressor-induced gastrointestinal disease.

#SentiaMedical #IBS #CRF #stressors

SentiaMedical.com

Listen to the podcast here

Catherine Rivier, Co-Founder Sentia Medical is an expert on stressors and the impact physical, emotional, and infectious or inflammatory stressors have on the brain and the body. Her research along with her late husband at the Salk Institute in San Diego led to the discovery of the main stress hormone CRF. Sentia is now developing astressins - compounds that will counter some of the effects of stressor on the body. Their focus is treating irritable bowel syndrome, a key stressor-induced gastrointestinal disease.

#SentiaMedical #IBS #CRF #stressors

SentiaMedical.com

Download the transcript here

Tara Davis Director of Community Health, Rimidi has deep expertise in the development and evaluation of public health prevention programs. She explains why it has become exponentially more difficult to ensure minorities, low income, rural and patients living with chronic conditions to receive even basic care they need as a result of being disproportionately affected by COVID-19. Tara emphasizes the essential role technology must play in enabling data-driven healthcare and how the expanding use of mobile devices is leading to more opportunities to help vulnerable populations who need care.

#COVID19 #digitalhealth #telehealth

Rimidi.com

Listen to the podcast here

Tara Davis Director of Community Health, Rimidi has deep expertise in the development and evaluation of public health prevention programs. She explains why it has become exponentially more difficult to ensure minorities, low income, rural and patients living with chronic conditions to receive even basic care they need as a result of being disproportionately affected by COVID-19. Tara emphasizes the essential role technology must play in enabling data-driven healthcare and how the expanding use of mobile devices is leading to more opportunities to help vulnerable populations who need care.

#COVID19 #digitalhealth #telehealth

Rimidi.com

Download the transcript here

Dr. Sheri Prentiss, physician and founder LIVE Today Foundation and Rick Carreon, CEO and President, Impedimed are excited about their partnership to raise awareness about early diagnosis and treatment of lymphedema to prevent it from becoming a chronic condition. The Impedimed device conducts a simple and fast test to detect small fluid shifts of lymphatic fluid building. Results alert doctors about the presence of lymphedema allowing them to stop the progression or reverse it. Working together, Sheri and Rick are educating clinicians and patients about this life changing approach for five and a half million cancer survivors living with lymphedema in the US today.

@LIVETodayDotOrg. @Impedimed #lymphedema #breastcancer

LIVE-today.org

Impedimed.com

Listen to the podcast here.

Dr. Sheri Prentiss, physician and founder LIVE Today Foundation and Rick Carreon, CEO and President, Impedimed are excited about their partnership to raise awareness about early diagnosis and treatment of lymphedema to prevent it from becoming a chronic condition. The Impedimed device conducts a simple and fast test to detect small fluid shifts of lymphatic fluid building. Results alert doctors about the presence of lymphedema allowing them to stop the progression or reverse it. Working together, Sheri and Rick are educating clinicians and patients about this life changing approach for five and a half million cancer survivors living with lymphedema in the US today.

@LIVETodayDotOrg. @Impedimed #lymphedema #breastcancer

LIVE-today.org

Impedimed.com

Download the transcript here.